Skip to main navigation menu Skip to main content Skip to site footer

Clinical and epidemiological characterization of chronic obstructive pulmonary disease

Caracterización clínica y epidemiológica de la enfermedad pulmonar obstructiva crónica




Section
Research Article

How to Cite
Martinez-Sanchez, L. M., Lopez Lopez, L., Roldan-Tabares, M. D., Herrera-Almanza, L., Lobo-Salas, Y. F., Arboleda-Rojas, M., Uribe-Molina, A. M., Duque-Ocampo, M. del M., Hernández-Martínez, A., & Morales-Quintero, N. (2023). Clinical and epidemiological characterization of chronic obstructive pulmonary disease. Journal of Medicine and Surgery Repertoire, 33(2), 158-162. https://doi.org/10.31260/RepertMedCir.01217372.1455

Dimensions
PlumX
Citations
license

   


Lina Maria Martinez-Sanchez,

Docente Interno. Facultad de Medicina Universidad Pontificia Bolivariana. Medellin, Colombia.


Lucelly Lopez Lopez,

Docente Interno Facultad de Medicina Universidad Pontificia Bolivariana. Medellín, Colombia.


Mabel Dahiana Roldan-Tabares,

Estudiante de Medicina. Facultad de Medicina Universidad Pontificia Bolivariana. Medellín.


Laura Herrera-Almanza,

Estudiante de Medicina. Facultad de Medicina Universidad Pontificia Bolivariana. Medellín.


Yulis Fernanda Lobo-Salas,

Estudiante de Medicina. Facultad de Medicina Universidad Pontificia Bolivariana. Medellín.


Manuela Arboleda-Rojas,

Estudiante de Medicina. Facultad de Medicina Universidad Pontificia Bolivariana. Medellín.


Ana María Uribe-Molina,

Estudiante de Medicina. Facultad de Medicina Universidad Pontificia Bolivariana. Medellín.


María del Mar Duque-Ocampo,

Estudiante de Medicina. Facultad de Medicina Universidad Pontificia Bolivariana. Medellín.


Alejandro Hernández-Martínez,

Estudiante de Medicina. Facultad de Medicina Universidad Pontificia Bolivariana. Medellín.


Objective: clinical and epidemiological characterization of patients with chronic obstructive pulmonary disease (COPD). Methods: a retrospective, cross-sectional, descriptive study, which included adult patients with a diagnosis of COPD in a university hospital in Medellín. Data sources were secondary, based on medical records. The Jamovi program was used to perform a univariate analysis. Results and discussion: 552 patients were included. Median age was 76 years with a female predominance (56.7%). Regarding exposure to major respiratory toxic substances implicated in the development of the disease, 24.1% were tobacco smokers and 23% were exposed to biomass smoke. At the time of hospital admission,17.9% were classified as having grade 4 dyspnea; 74.1% received short acting beta-agonists and 60% short-acting antimuscarinics,11.6% required intensive care unit or special care unit admission, and 7.8% died in hospital. Conclusions: under-diagnosis of COPD by spirometry may be related to economic, technological, and trained human resource limitations, which affect adequate diagnosis and management of the disease, as well as patient´s quality of life.


Article visits 1238 | PDF visits 1123


Downloads

Download data is not yet available.
  1. Patel AR, Patel AR, Singh S, Singh S, Khawaja I. Global Initiative for Chronic Obstructive Lung Disease: The Changes Made. Cureus. 2019;11(6):e4985. https://doi.org/10.7759/cureus.4985. DOI: https://doi.org/10.7759/cureus.4985
  2. Vogelmeier CF, Criner GJ, Martínez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. Arch Bronconeumol. 2017;53(3):128-149. https://doi.org/10.1016/j.arbres.2017.02.001. DOI: https://doi.org/10.1016/j.arbr.2017.02.001
  3. Organización Mundial de la Salud. Las 10 principales causas de defunción [Internet]. Washington: Organización Mundial de la Salud; 2020 [citado 26 mayo de 2022]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/the-top-10-causes-of-death
  4. Organización Mundial de la Salud. Enfermedad pulmonar obstructiva crónica (EPOC): datos y cifras [Internet]. Washington: OMS; 2022 [citado 26 mayo de 2022]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)
  5. Ministerio de Salud y Protección Social. Enfermedad pulmonar obstructiva crónica (EPOC) [Internet]. Bogotá: MINSALUD; 2022 [citado 26 mayo de 2022]. Disponible en: https://www.minsalud.gov.co/salud/publica/PENT/Paginas/Enfermedad-pulmonar-obstructiva-cronica.aspx
  6. Mirza S, Benzo R. Chronic Obstructive Pulmonary Disease Phenotypes: Implications for Care. Mayo Clin Proc. 2017;92(7):1104-1112. https://doi.org/10.1016/j.mayocp.2017.03.020. DOI: https://doi.org/10.1016/j.mayocp.2017.03.020
  7. Díez JM. Papel del recuento de eosinófilos en sangre como un biomarcador en la EPOC: luces y sombras. Rev Patol Respir. 2018;21(1):1-3. DOI: https://doi.org/10.19134/eutomia-v1i22p1-14
  8. Camargo B, DiTullio F, Bosio M, Smith R, Borsini E, Canzonieri R, et al. Heterogeneidad en los fenotipos inflamatorios de los pacientes con EPOC: rol del recuento celular diferencial en esputo. RAMR.2016;16(2):128-136.
  9. Herrera-García JC, Montiel-Castro JS, Caballero-López CG. Prevalencia de eosinofilia y características clínicas en una cohorte de pacientes con enfermedad pulmonar obstructiva crónica en un hospital de tercer nivel de Puebla. Med Int Méx. 2018;34(5):692-696. https://doi.org/10.24245/mim.v34i5.2059. DOI: https://doi.org/10.24245/mim.v34i5.2059
  10. The jamovi project. jamovi. (Version 2.3) [Computer Software]. 2022 [citado 26 mayo de 2022]. Retrieved from https://www.jamovi.org.
  11. R Core Team (2021). R: A Language and environment for statistical computing. (Version 4.1) [Computer software). 2022 [citado 26 mayo de 2022]. Retrieved from https;//cran.r-project.org. (R packages retrieved from MRAN snapshot 2022-01-01).
  12. Fernández-García S, Represas-Represas C, Ruano-Raviña A, Mosteiro-Añón M, Mouronte-Roibas C, Fernández-Villar A. Social Profile of Patients Admitted for COPD Exacerbations. A Gender Analysis. Arch Bronconeumol. 2020;56(2):84-89. https://doi.org/10.1016/j.arbr.2019.03.021. DOI: https://doi.org/10.1016/j.arbr.2019.03.021
  13. Fernández-García S, Represas-Represas C, Ruano-Raviña A, Botana-Rial M, Martínez-Reglero C, Fernández Villar A. Dependence IN Performing Activities as a Predictor of Mortality Following Hospitalization for Chronic Obstructive Pulmonary Disease Exacerbation. Arch Bronconeumol. 2020;56(5):291-297. https://doi.org/10.1016/j.arbres.2019.10.005. DOI: https://doi.org/10.1016/j.arbr.2020.03.004
  14. Rojas Gil Y, Torres Duque CA, Figueredo MC, Hernández F, Castañeda Cardona C, Lasalvia P, et al. Estimación de la prevalencia de EPOC en Colombia a partir del Registro Individual de Prestaciones de Servicios de Salud (RIPS). Revista Colombiana de Neumología. 2019,31(1):5-15. http://dx.doi.org/10.30789/rcneumologia.v31.n1.2019.325. DOI: https://doi.org/10.30789/rcneumologia.v31.n1.2019.325
  15. Olloquequi J, Jaime S, Parra V, Muñoz C, Muñoz A, Lastra F, et al. Caracterización general de los pacientes con EPOC de la Región del Maule: resultados preliminares del estudio MaulEPOC. Rev Chil Enferm Respir. 2017;33(4):284-92. http://dx.doi.org/10.4067/S0717-73482017000400284. DOI: https://doi.org/10.4067/S0717-73482017000400284
  16. Agudelo C, Martínez L, Ortiz I, Rodríguez M, Zuluaga M, Perilla N, et al. Perfil clínico y epidemiológico de pacientes con enfermedad pulmonar obstructiva crónica hospitalizados en un centro de alta complejidad de la ciudad de Medellín, Colombia, durante el año 2015. Rev Investig Andin. 2018;20(37):151-60. https://doi.org/10.33132/01248146.987. DOI: https://doi.org/10.33132/01248146.987
Sistema OJS 3.4.0.5 - Metabiblioteca |